AngioDynamics Company Profile (NASDAQ:ANGO)

About AngioDynamics (NASDAQ:ANGO)

AngioDynamics logoAngioDynamics, Inc. designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. The Company's devices are used in minimally invasive, image-guided procedures. The Company offers products within three product groupings: Peripheral Vascular, Vascular Access and Oncology/Surgery. The Company's Peripheral Vascular products include Fluid Management, Venous, Thrombus Management, as well as other core products. The Company's BioFlo products incorporate Endexo Technology into the manufacturing and design of its Vascular Access products. Its Oncology/Surgery product offerings include its Microwave Ablation products, Radiofrequency Ablation (RFA) and its NanoKnife product lines.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Supplies
  • Sub-Industry: Health Care Equipment
  • Symbol: NASDAQ:ANGO
  • CUSIP: 03475V10
  • Web: www.angiodynamics.com
Capitalization:
  • Market Cap: $561.4 million
  • Outstanding Shares: 36,780,000
Average Prices:
  • 50 Day Moving Avg: $15.88
  • 200 Day Moving Avg: $16.23
  • 52 Week Range: $14.80 - $18.18
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 19.44
  • P/E Growth: 1.76
Sales & Book Value:
  • Annual Revenue: $356.15 million
  • Price / Sales: 1.63
  • Book Value: $14.46 per share
  • Price / Book: 1.09
Profitability:
  • EBIDTA: $49.13 million
  • Net Margins: 2.00%
  • Return on Equity: 5.19%
  • Return on Assets: 3.79%
Debt:
  • Debt-to-Equity Ratio: 0.18%
  • Current Ratio: 2.21%
  • Quick Ratio: 1.73%
Misc:
  • Average Volume: 235,332 shs.
  • Beta: 1.15
  • Short Ratio: 6.27
 

Frequently Asked Questions for AngioDynamics (NASDAQ:ANGO)

What is AngioDynamics' stock symbol?

AngioDynamics trades on the NASDAQ under the ticker symbol "ANGO."

How were AngioDynamics' earnings last quarter?

AngioDynamics, Inc. (NASDAQ:ANGO) posted its earnings results on Tuesday, July, 18th. The company reported $0.19 EPS for the quarter, beating the Zacks' consensus estimate of $0.16 by $0.03. The company had revenue of $86.90 million for the quarter, compared to the consensus estimate of $90.72 million. AngioDynamics had a return on equity of 5.19% and a net margin of 2.00%. The company's revenue for the quarter was down 7.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.19 earnings per share. View AngioDynamics' Earnings History.

When will AngioDynamics make its next earnings announcement?

AngioDynamics is scheduled to release their next quarterly earnings announcement on Tuesday, October, 3rd 2017. View Earnings Estimates for AngioDynamics.

What guidance has AngioDynamics issued on next quarter's earnings?

AngioDynamics updated its FY18 earnings guidance on Tuesday, July, 18th. The company provided earnings per share (EPS) guidance of $0.64-0.68 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.68. The company issued revenue guidance of $352-359 million, compared to the consensus revenue estimate of $357.75 million.

Where is AngioDynamics' stock going? Where will AngioDynamics' stock price be in 2017?

5 analysts have issued twelve-month target prices for AngioDynamics' stock. Their forecasts range from $16.00 to $21.00. On average, they anticipate AngioDynamics' share price to reach $18.40 in the next year. View Analyst Ratings for AngioDynamics.

What are analysts saying about AngioDynamics stock?

Here are some recent quotes from research analysts about AngioDynamics stock:

  • 1. According to Zacks Investment Research, "AngioDynamics reported a mixed fourth quarter of fiscal 2017, wherein adjusted earnings beat the Zacks Consensus Estimate while revenues missed the same. The year-over-year decline at the company’s Peripheral Vascular, Vascular Access and Oncology & Surgery business segments marred revenues. Furthermore, the company expects earnings to fall sequentially in FY18. Lackluster performance by the oncology segment was primarily due to market withdrawal of the company’s flagship Acculis Microwave Tissue Ablation System, which also marred international sales. AngioDynamics has a high outstanding debt level at the end of the fourth quarter. This is likely to impose certain operating and financial restrictions, limiting the company’s core business strategies. Over the last one year, AngioDynamics has underperformed the broader industry in terms of price. However, growth in the core Angiographic Catheter business holds promise." (7/20/2017)
  • 2. Cantor Fitzgerald analysts commented, "F3Q17 Result Summary. F3Q17 total revenues of $85.6M (down 2.0% y/y), was $3.2M below our estimate of $88.8M and $2.7M below FactSet consensus of $88.3M." (3/30/2017)

Who are some of AngioDynamics' key competitors?

Who are AngioDynamics' key executives?

AngioDynamics' management team includes the folowing people:

  • Howard W. Donnelly, Independent Chairman of the Board
  • James C. Clemmer, President, Chief Executive Officer, Director
  • Michael Greiner, Chief Financial Officer, Executive Vice President
  • Gary Barrett, Senior Vice President,Quality and Regulatory Affairs
  • Ben Davis, Senior Vice President, Business Development
  • Barbara Kucharczyk, Senior Vice President-Global Operations
  • Stephen A. Trowbridge, Senior Vice President, General Counsel
  • Eileen O'Shea Auen, Director
  • Jan Stern Reed, Director
  • David F. Burgstahler, Independent Director

Who owns AngioDynamics stock?

AngioDynamics' stock is owned by a variety of of institutional and retail investors. Top institutional investors include Peregrine Capital Management LLC (2.04%), Fenimore Asset Management Inc. (1.57%), Bank of Montreal Can (0.71%), First Quadrant L P CA (0.31%), Capital One National Association (0.25%) and Louisiana State Employees Retirement System (0.04%). Company insiders that own AngioDynamics stock include Avista Capital Partners Gp, Ll, Charles R Greiner, David F Burgstahler and Stephen A Trowbridge. View Institutional Ownership Trends for AngioDynamics.

Who bought AngioDynamics stock? Who is buying AngioDynamics stock?

AngioDynamics' stock was acquired by a variety of institutional investors in the last quarter, including Peregrine Capital Management LLC, Bank of Montreal Can, Fenimore Asset Management Inc., GW&K Investment Management LLC, First Quadrant L P CA, Capital One National Association, State of Alaska Department of Revenue and Louisiana State Employees Retirement System. View Insider Buying and Selling for AngioDynamics.

How do I buy AngioDynamics stock?

Shares of AngioDynamics can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is AngioDynamics' stock price today?

One share of AngioDynamics stock can currently be purchased for approximately $15.75.


MarketBeat Community Rating for AngioDynamics (NASDAQ ANGO)
Community Ranking:  1.8 out of 5 ()
Outperform Votes:  91 (Vote Outperform)
Underperform Votes:  165 (Vote Underperform)
Total Votes:  256
MarketBeat's community ratings are surveys of what our community members think about AngioDynamics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for AngioDynamics (NASDAQ:ANGO) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 2 Hold Ratings, 3 Buy Ratings
Consensus Rating:Buy (Score: 2.60)
Consensus Price Target: $18.40 (16.83% upside)

Analysts' Ratings History for AngioDynamics (NASDAQ:ANGO)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
7/19/2017Barclays PLCLower Price TargetEqual Weight$17.00 -> $16.00LowView Rating Details
7/18/2017Canaccord GenuityReiterated RatingHold$17.00MediumView Rating Details
7/4/2017Cantor FitzgeraldBoost Price TargetOverweight$20.00 -> $21.00LowView Rating Details
4/1/2017Craig HallumSet Price TargetBuy$20.00LowView Rating Details
9/12/2016KeyCorpSet Price TargetBuy$18.00N/AView Rating Details
4/8/2016Piper Jaffray CompaniesInitiated CoverageNeutral$12.00N/AView Rating Details
11/10/2015Raymond James Financial, Inc.DowngradeOutperform -> Market PerformN/AView Rating Details
9/23/2015SidotiInitiated CoverageNeutral$14.50N/AView Rating Details
(Data available from 7/21/2015 forward)

Earnings

Earnings History for AngioDynamics (NASDAQ:ANGO)
Earnings by Quarter for AngioDynamics (NASDAQ:ANGO)
Earnings History by Quarter for AngioDynamics (NASDAQ ANGO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/3/2017$0.16N/AView Earnings Details
7/18/2017Q4 2017$0.16$0.19$90.72 million$86.90 millionViewN/AView Earnings Details
3/30/2017Q3 2017$0.15$0.19$88.29 million$85.60 millionViewN/AView Earnings Details
1/6/2017Q217$0.16$0.19$91.09 million$89.00 millionViewListenView Earnings Details
10/5/2016Q117$0.13$0.17$86.09 million$88.10 millionViewN/AView Earnings Details
7/13/2016Q416$0.16$0.19$88.64 million$93.40 millionViewListenView Earnings Details
4/7/2016Q3$0.14$0.15$85.43 million$87.40 millionViewListenView Earnings Details
1/7/2016Q216$0.14$0.14$88.67 million$89.20 millionViewN/AView Earnings Details
10/8/2015Q116$0.11$0.11$84.70 million$83.70 millionViewN/AView Earnings Details
7/16/2015Q415$0.14$0.14$91.67 million$90.90 millionViewListenView Earnings Details
4/9/2015Q315$0.15$0.12$88.69 million$86.60 millionViewN/AView Earnings Details
1/8/2015Q215$0.15$0.17$90.90 million$92.10 millionViewN/AView Earnings Details
10/9/2014Q115$0.11$0.16$85.35 million$87.30 millionViewListenView Earnings Details
7/23/2014Q414$0.12$0.18$93.65 million$94.07 millionViewListenView Earnings Details
4/9/2014Q314$0.09$0.16$86.85 million$88.20 millionViewListenView Earnings Details
1/9/2014Q2$0.07$0.14$87.54 million$88.60 millionViewListenView Earnings Details
10/10/2013Q114$0.03$0.04$82.54 million$83.60 millionViewN/AView Earnings Details
7/11/2013Q4 2013$0.06$0.07$86.43 million$90.00 millionViewN/AView Earnings Details
4/8/2013Q3 2013$0.05$0.08$81.70 million$81.60 millionViewN/AView Earnings Details
1/3/2013Q2 2013$0.09$0.10$87.40 million$87.00 millionViewN/AView Earnings Details
10/8/2012Q113$0.09$0.10$84.35 million$83.40 millionViewN/AView Earnings Details
7/12/2012$0.08$0.09ViewN/AView Earnings Details
4/4/2012$0.07$0.09ViewN/AView Earnings Details
1/5/2012$0.12$0.13ViewN/AView Earnings Details
10/6/2011$0.09$0.08ViewN/AView Earnings Details
7/14/2011$0.10$0.11ViewN/AView Earnings Details
4/5/2011$0.12$0.15ViewN/AView Earnings Details
1/4/2011$0.12$0.13ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for AngioDynamics (NASDAQ:ANGO)
2017 EPS Consensus Estimate: $0.61
2018 EPS Consensus Estimate: $0.68
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171$0.13$0.13$0.13
Q2 20171$0.17$0.17$0.17
Q3 20172$0.15$0.16$0.16
Q4 20172$0.14$0.16$0.15
Q1 20182$0.14$0.18$0.16
Q2 20182$0.15$0.17$0.16
Q3 20182$0.18$0.23$0.21
Q4 20181$0.15$0.15$0.15
(Data provided by Zacks Investment Research)

Dividends

Dividend History for AngioDynamics (NASDAQ:ANGO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for AngioDynamics (NASDAQ:ANGO)
Insider Ownership Percentage: 1.88%
Institutional Ownership Percentage: 84.64%
Insider Trades by Quarter for AngioDynamics (NASDAQ:ANGO)
Institutional Ownership by Quarter for AngioDynamics (NASDAQ:ANGO)
Insider Trades by Quarter for AngioDynamics (NASDAQ:ANGO)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/12/2017Avista Capital Partners Gp, LlMajor ShareholderSell2,350,000$16.00$37,600,000.00View SEC Filing  
8/5/2016Avista Capital Partners Gp, LlMajor ShareholderSell2,241,000$14.62$32,763,420.00View SEC Filing  
8/5/2016David F BurgstahlerDirectorSell2,250,000$14.62$32,895,000.00View SEC Filing  
5/6/2016Charles R GreinerVPSell3,508$12.31$43,183.48View SEC Filing  
4/25/2016Stephen A TrowbridgeSVPSell12,940$12.30$159,162.00View SEC Filing  
4/14/2014Matthew KapustaSVPBuy1,000$13.90$13,900.00View SEC Filing  
10/18/2013Vincent BucciDirectorBuy5,000$15.20$76,000.00View SEC Filing  
10/17/2013Howard W DonnellyDirectorSell20,000$15.06$301,200.00View SEC Filing  
7/22/2013Kevin J GouldDirectorBuy2,700$12.00$32,400.00View SEC Filing  
5/9/2013Charles R GreinerVPSell1,495$10.38$15,518.10View SEC Filing  
3/12/2013Vincent BucciDirectorBuy85,000$10.77$915,450.00View SEC Filing  
2/14/2013Vincent BucciDirectorBuy2,000$12.17$24,340.00View SEC Filing  
1/11/2013Kevin J GouldDirectorBuy2,700$11.58$31,266.00View SEC Filing  
11/5/2012Jeffrey GoldDirectorBuy1,000$10.56$10,560.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for AngioDynamics (NASDAQ:ANGO)
Latest Headlines for AngioDynamics (NASDAQ:ANGO)
Source:
DateHeadline
americanbankingnews.com logoAngioDynamics, Inc. (NASDAQ:ANGO) Cut to Sell at Zacks Investment Research
www.americanbankingnews.com - July 20 at 2:34 PM
americanbankingnews.com logoCraig Hallum Comments on AngioDynamics, Inc.'s FY2018 Earnings (ANGO)
www.americanbankingnews.com - July 20 at 1:48 PM
americanbankingnews.com logoAngioDynamics, Inc. (ANGO) Forecasted to Post Q1 2018 Earnings of $0.14 Per Share
www.americanbankingnews.com - July 20 at 12:42 PM
finance.yahoo.com logoAngioDynamics, Inc. breached its 50 day moving average in a Bearish Manner : ANGO-US : July 19, 2017
finance.yahoo.com - July 19 at 5:04 PM
americanbankingnews.com logoBarclays PLC Cuts AngioDynamics, Inc. (NASDAQ:ANGO) Price Target to $16.00
www.americanbankingnews.com - July 19 at 3:05 PM
finance.yahoo.com logoEdited Transcript of ANGO earnings conference call or presentation 18-Jul-17 12:00pm GMT
finance.yahoo.com - July 19 at 3:27 AM
seekingalpha.com logoAngioDynamics, Inc. (ANGO)
seekingalpha.com - July 18 at 10:25 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of AngioDynamics, Inc.
finance.yahoo.com - July 18 at 10:25 PM
finance.yahoo.com logoANGIODYNAMICS (ANGO) INVESTOR ALERT: Legal Investigation for Potential Securities Law Violations
finance.yahoo.com - July 18 at 10:25 PM
finance.yahoo.com logoIMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of AngioDynamics, Inc. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - July 18 at 10:25 PM
americanbankingnews.com logoAngioDynamics, Inc. (NASDAQ:ANGO) Given Average Rating of "Buy" by Analysts
www.americanbankingnews.com - July 18 at 6:56 PM
finance.yahoo.com logoAngioDynamics Reports Fiscal 2017 Fourth Quarter and Full-Year Results
finance.yahoo.com - July 18 at 5:23 PM
finance.yahoo.com logoAngioDynamics Reports Fiscal 2017 Fourth Quarter and Full-Year Results
finance.yahoo.com - July 18 at 5:23 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AngioDynamics, Inc. - ANGO
finance.yahoo.com - July 18 at 5:23 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AngioDynamics, Inc. - ANGO
finance.yahoo.com - July 18 at 5:23 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of AngioDynamics, Inc.
finance.yahoo.com - July 18 at 5:23 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of AngioDynamics, Inc.
finance.yahoo.com - July 18 at 5:23 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AngioDynamics, Inc. (ANGO)
finance.yahoo.com - July 18 at 5:23 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AngioDynamics, Inc. (ANGO)
finance.yahoo.com - July 18 at 5:23 PM
finance.yahoo.com logoANGIODYNAMICS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In AngioDynamics, Inc. To Contact The Firm
finance.yahoo.com - July 18 at 5:23 PM
finance.yahoo.com logoANGIODYNAMICS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In AngioDynamics, Inc. To Contact The Firm
finance.yahoo.com - July 18 at 5:23 PM
finance.yahoo.com logoIMPORTANT INVESTOR ALERT: Lundin Law PC Announces an Investigation of AngioDynamics, Inc.
finance.yahoo.com - July 18 at 5:23 PM
finance.yahoo.com logoIMPORTANT INVESTOR ALERT: Lundin Law PC Announces an Investigation of AngioDynamics, Inc.
finance.yahoo.com - July 18 at 5:23 PM
finance.yahoo.com logoAngioDynamics reports 4Q loss
finance.yahoo.com - July 18 at 5:23 PM
finance.yahoo.com logoAngioDynamics reports 4Q loss
finance.yahoo.com - July 18 at 5:23 PM
americanbankingnews.com logoCanaccord Genuity Reiterates "Hold" Rating for AngioDynamics, Inc. (NASDAQ:ANGO)
www.americanbankingnews.com - July 18 at 4:17 PM
americanbankingnews.com logoAngioDynamics, Inc. (NASDAQ:ANGO) Announces Earnings Results
www.americanbankingnews.com - July 18 at 11:35 AM
americanbankingnews.com logoAngioDynamics, Inc. (ANGO) Updates FY18 Earnings Guidance
www.americanbankingnews.com - July 18 at 11:34 AM
americanbankingnews.com logoFinancial Comparison: AngioDynamics (ANGO) and Teleflex (TFX)
www.americanbankingnews.com - July 14 at 6:36 PM
americanbankingnews.com logoAngioDynamics, Inc. (NASDAQ:ANGO) Set to Announce Earnings on Tuesday
www.americanbankingnews.com - July 14 at 7:10 AM
americanbankingnews.com logoZacks: Analysts Anticipate AngioDynamics, Inc. (NASDAQ:ANGO) Will Post Quarterly Sales of $90.76 Million
www.americanbankingnews.com - July 13 at 10:00 AM
americanbankingnews.com logoAngioDynamics, Inc. (ANGO) Expected to Announce Earnings of $0.16 Per Share
www.americanbankingnews.com - July 11 at 4:20 PM
americanbankingnews.com logoAngioDynamics (NASDAQ:ANGO) vs. Teleflex (TFX) Critical Survey
www.americanbankingnews.com - July 8 at 12:28 PM
feeds.benzinga.com logoAngioDynamics to Report Fiscal 2017 Fourth Quarter and Full-Year Financial Results
feeds.benzinga.com - July 7 at 6:25 AM
americanbankingnews.com logoHead-To-Head Contrast: Teleflex (TFX) vs. AngioDynamics (NASDAQ:ANGO)
www.americanbankingnews.com - July 1 at 8:12 AM
americanbankingnews.com logoContrasting Becton, Dickinson and Company (BDX) & AngioDynamics (ANGO)
www.americanbankingnews.com - June 29 at 12:04 PM
americanbankingnews.com logoBrokers Set Expectations for AngioDynamics, Inc.'s FY2018 Earnings (ANGO)
www.americanbankingnews.com - June 26 at 11:28 AM
americanbankingnews.com logoAngioDynamics, Inc. (ANGO) Given Consensus Rating of "Buy" by Analysts
www.americanbankingnews.com - June 23 at 5:08 PM
americanbankingnews.com logo Brokerages Anticipate AngioDynamics, Inc. (ANGO) Will Announce Quarterly Sales of $90.76 Million
www.americanbankingnews.com - June 17 at 8:48 AM
finance.yahoo.com logoETFs with exposure to AngioDynamics, Inc. : June 15, 2017
finance.yahoo.com - June 15 at 5:12 PM
finance.yahoo.com logoAngioDynamics, Inc. – Value Analysis (NASDAQ:ANGO) : June 15, 2017
finance.yahoo.com - June 15 at 5:12 PM
americanbankingnews.com logo Analysts Anticipate AngioDynamics, Inc. (ANGO) Will Post Earnings of $0.16 Per Share
www.americanbankingnews.com - June 15 at 4:16 PM
finance.yahoo.com logoAngioDynamics, Inc. breached its 50 day moving average in a Bullish Manner : ANGO-US : June 14, 2017
finance.yahoo.com - June 14 at 10:43 AM
finance.yahoo.com logoFeatured Company News - Medical Devices Company AngioDynamics Receives FDA Clearance for Solero MTA System
finance.yahoo.com - June 9 at 3:51 PM
streetinsider.com logoAngioDynamics (ANGO) Granted FDA Clearance for The Solero Microwave Tissue Ablation System
www.streetinsider.com - June 8 at 1:46 AM
finance.yahoo.com logoAngioDynamics Announces FDA Clearance for The Solero Microwave Tissue Ablation System
finance.yahoo.com - June 7 at 3:41 PM
americanbankingnews.com logoAngioDynamics, Inc. (ANGO) Given Hold Rating at Canaccord Genuity
www.americanbankingnews.com - May 31 at 9:32 PM
finance.yahoo.com logoAlbany public company files lawsuit alleging competitor violated antitrust laws
finance.yahoo.com - May 31 at 3:32 PM
americanbankingnews.com logoAngioDynamics, Inc. (ANGO) Given Consensus Recommendation of "Buy" by Analysts
www.americanbankingnews.com - May 29 at 4:56 PM
americanbankingnews.com logoAnalysts Set AngioDynamics, Inc. (ANGO) Price Target at $18.70
www.americanbankingnews.com - May 5 at 11:44 PM

Social

Chart

AngioDynamics (ANGO) Chart for Friday, July, 21, 2017

This page was last updated on 7/21/2017 by MarketBeat.com Staff